Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business

Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to potentially sell and purchase a 50% controlling stake in Opella, Sanofi’s consumer health unit.  

The new step in Opella’s journey paves the way for creating a standalone player in consumer healthcare while supporting Sanofi’s strategy and increased focus on innovative medicines and vaccines.

Sanofi would remain a significant shareholder in Opella.

Also Read: Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R.

Bpifrance is expected to be a minority shareholder with a c.2% stake.

Headquartered in France, Opella employs over 11,000 people and operates in 100 countries. It has 13 manufacturing sites and four ...